Beijing Succeeder Technology Future Growth
Future criteria checks 4/6
Beijing Succeeder Technology is forecast to grow earnings and revenue by 21.3% and 24.3% per annum respectively. EPS is expected to grow by 21.4% per annum. Return on equity is forecast to be 9.7% in 3 years.
Key information
21.3%
Earnings growth rate
21.4%
EPS growth rate
Medical Equipment earnings growth | 22.6% |
Revenue growth rate | 24.3% |
Future return on equity | 9.7% |
Analyst coverage | Low |
Last updated | 07 Jun 2024 |
Recent future growth updates
No updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 541 | 206 | N/A | 205 | 1 |
12/31/2025 | 431 | 170 | N/A | 163 | 1 |
12/31/2024 | 344 | 141 | N/A | 108 | 1 |
6/30/2024 | 293 | 119 | -15 | 116 | N/A |
3/31/2024 | 285 | 121 | -20 | 110 | N/A |
12/31/2023 | 275 | 117 | -11 | 110 | N/A |
9/30/2023 | 269 | 114 | -7 | 99 | N/A |
6/30/2023 | 264 | 117 | 29 | 113 | N/A |
3/31/2023 | 246 | 112 | 15 | 117 | N/A |
12/31/2022 | 229 | 104 | 3 | 101 | N/A |
9/30/2022 | 240 | 109 | 21 | 112 | N/A |
6/30/2022 | 235 | 103 | 35 | 104 | N/A |
3/31/2022 | 238 | 96 | 64 | 104 | N/A |
12/31/2021 | 240 | 97 | 92 | 107 | N/A |
9/30/2021 | 235 | 96 | 98 | 101 | N/A |
6/30/2021 | 234 | 86 | 87 | 90 | N/A |
3/31/2021 | 241 | 85 | 57 | 90 | N/A |
12/31/2020 | 222 | 69 | 40 | 72 | N/A |
9/30/2020 | 222 | 63 | 29 | 60 | N/A |
6/30/2020 | 220 | 66 | 18 | 50 | N/A |
3/31/2020 | 207 | 59 | 31 | 35 | N/A |
12/31/2019 | 230 | 71 | 56 | 61 | N/A |
12/31/2018 | 200 | 57 | 54 | 58 | N/A |
12/31/2017 | 157 | 29 | N/A | 33 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 688338's forecast earnings growth (21.3% per year) is above the savings rate (2.9%).
Earnings vs Market: 688338's earnings (21.3% per year) are forecast to grow slower than the CN market (21.9% per year).
High Growth Earnings: 688338's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 688338's revenue (24.3% per year) is forecast to grow faster than the CN market (13.4% per year).
High Growth Revenue: 688338's revenue (24.3% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 688338's Return on Equity is forecast to be low in 3 years time (9.7%).